 | • レポートコード：MRC2209A006 • 出版社/出版日：Persistence Market Research / 2022年5月 • レポート形態：英文、PDF、242ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の本調査レポートでは、世界のバイオベター市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、需要分析・予測、市場背景、製品タイプ別（エリスロポエチン製剤バイオベター、G-CSF製剤バイオベター、インターフェロン製剤バイオベター、インスリン製剤バイオベター）分析、疾患別（糖尿病、癌、腎臓病、神経変性疾患）分析、投与経路別（皮下投与、静脈内投与）分析、流通チャネル別（病院薬局、小売店薬局、オンライン薬局）分析、地域別分析（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。なお、主要企業として、Amgen Inc.、F. Hoffmann-La Roche AG、Merck & Co. Inc.、Sanofi SA、SERVIER、Porton Biopharma Limited、Eli Lily and Company、Novo Nordisk A/S、Biogen Inc.、CSL Behring GmbH、Teva Pharmaceutical Industries Ltd.などが含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・需要分析・予測 ・市場背景 ・世界のバイオベター市場規模：製品タイプ別 - エリスロポエチン製剤バイオベターにおける市場規模 - G-CSF製剤バイオベターにおける市場規模 - インターフェロン製剤バイオベターにおける市場規模 - インスリン製剤バイオベターにおける市場規模 ・世界のバイオベター市場規模：疾患別 - 糖尿病における市場規模 - 癌における市場規模 - 腎臓病における市場規模 - 神経変性疾患における市場規模 ・世界のバイオベター市場規模：投与経路別 - 皮下投与における市場規模 - 静脈内投与における市場規模 ・世界のバイオベター市場規模：流通チャネル別 - 病院薬局における市場規模 - 小売店薬局における市場規模 - オンライン薬局における市場規模 ・世界のバイオベター市場規模：地域別 - 北米のバイオベター市場規模 - 中南米のバイオベター市場規模 - ヨーロッパのバイオベター市場規模 - アジア太平洋のバイオベター市場規模 - 中東/アフリカのバイオベター市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Biobetters Market Analysis 2022 – 2029
A recent market study published by Persistence Market Research (PMR) on the Biobetters Market including global industry analysis for 2014-2021 & opportunity assessment for 2022 – 2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.
Biobetters Market: Segmentation
The global Biobetters Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Molecule Type
G-CSF Biobetters
Insulin Biobetters
Erythropoietin Biobetters
Monoclonal Antibodies Biobetters
Others
Disease Indication
Cancer
Diabetes
Genetic disease
Neurological Disorders
Others
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa (MEA)
Key Questions Answered in Report
The research study offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.
What are the key trends that are constantly shaping market growth?
Which are the prominent regions that offer plentiful opportunities for players in the market?
How has the outbreak of COVID-19 affected the market and what would the trend be like during the forecast period?
What are the differential strategies adopted by key players to hold a significant share in the Biobetters market?
Research Methodology
A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.
The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.
The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are F.Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, SERVIER, Porton Biopharma Limited, Eli Lily and Company, Novo Nordisk A/S, Biogen Inc., CSL Behring GmbH, and Teva Pharmaceutical Industries Ltd., among others.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Market Analysis
1.3. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Recent Product Launches
4.2. Promotional Strategies, by Manufacturers
4.3. Regulatory Scenario
5. Global Biobetters Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global Healthcare Spending Outlook
6.1.2. Global Pharmaceutical Outlook
6.1.3. Regional Healthcare Market Outlook
6.2. Forecast Factors – Relevance & Impact
6.2.1. Innovation of New Products
6.2.2. Increasing Research & Developmental Activities
6.2.3. Increasing Number of Biotechnology Industries And Research Institutes
6.2.4. Adoption of New Technologies In Research Field
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022 – 2029
7.3.1. Erythropoietin Biobetters
7.3.2. G-CSF Biobetters
7.3.3. Interferon Biobetters
7.3.4. Insulin Biobetters
7.3.5. Monoclonal Antibodies Biobetters
7.3.6. Anti-haemophilic Factor
7.3.7. Others
7.4. Market Attractiveness Analysis By Product Type
8. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, By Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 – 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022 – 2029
8.3.1. Diabetes
8.3.2. Cancer
8.3.3. Renal Disease
8.3.4. Neurodegenerative Disease
8.3.5. Genetic Disorders (Haemophilia)
8.3.6. Others
8.4. Market Attractiveness Analysis By Indication
9. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014 – 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 – 2029
9.3.1. Subcutaneous
9.3.2. Intravenous
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 – 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2029
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 – 2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. MEA
11.4. Market Attractiveness Analysis By Region
12. North America Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Indication
12.3.4. By Route of Administration
12.3.5. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Indication
12.4.4. By Route of Administration
12.4.5. By Distribution Channel
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Indication
13.3.4. By Route of Administration
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Indication
13.4.4. By Route of Administration
13.4.5. By Distribution Channel
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product Type
14.3.3. By Indication
14.3.4. By Route of Administration
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Indication
14.4.4. By Route of Administration
14.4.5. By Distribution Channel
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Indication
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Indication
15.4.4. By Route of Administration
15.4.5. By Distribution Channel
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Indication
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Indication
16.4.4. By Route of Administration
16.4.5. By Distribution Channel
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Indication
17.3.4. By Route of Administration
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Indication
17.4.4. By Route of Administration
17.4.5. By Distribution Channel
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 – 2029
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Indication
18.3.4. By Route of Administration
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Indication
18.4.4. By Route of Administration
18.4.5. By Distribution Channel
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. By Regional footprint of Players
19.3.2. Product foot print by Players
19.3.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Amgen Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments (Product/Channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.2. F. Hoffmann-La Roche AG
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.2.5.1. Marketing Strategy
20.3.2.5.2. Product Strategy
20.3.2.5.3. Channel Strategy
20.3.3. Merck & Co. Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.3.5.1. Marketing Strategy
20.3.3.5.2. Product Strategy
20.3.3.5.3. Channel Strategy
20.3.4. Sanofi SA
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.4.5.1. Marketing Strategy
20.3.4.5.2. Product Strategy
20.3.4.5.3. Channel Strategy
20.3.5. SERVIER
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.5.5.1. Marketing Strategy
20.3.5.5.2. Product Strategy
20.3.5.5.3. Channel Strategy
20.3.6. Porton Biopharma Limited
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.6.5.1. Marketing Strategy
20.3.6.5.2. Product Strategy
20.3.6.5.3. Channel Strategy
20.3.7. Eli Lily and Company
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.7.5.1. Marketing Strategy
20.3.7.5.2. Product Strategy
20.3.7.5.3. Channel Strategy
20.3.8. Novo Nordisk A/S
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.8.5.1. Marketing Strategy
20.3.8.5.2. Product Strategy
20.3.8.5.3. Channel Strategy
20.3.9. Biogen Inc.
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments (Product/Channel/Region)
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.9.5.1. Marketing Strategy
20.3.9.5.2. Product Strategy
20.3.9.5.3. Channel Strategy
20.3.10. CSL Behring GmbH
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments (Product/Channel/Region)
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.10.5.1. Marketing Strategy
20.3.10.5.2. Product Strategy
20.3.10.5.3. Channel Strategy
20.3.11. Teva Pharmaceutical Industries Ltd.
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Profitability by Market Segments (Product/Channel/Region)
20.3.11.4. Sales Footprint
20.3.11.5. Strategy Overview
20.3.11.5.1. Marketing Strategy
20.3.11.5.2. Product Strategy
20.3.11.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Table 01: Global Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product TypeTable 02: Global Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 03: Global Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 04: Global Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 05: Global Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Region
Table 06: North America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 07: North America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 08: North America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 09: North America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 10: North America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 11: Latin America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 12: Latin America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 13: Latin America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 14: Latin America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 15: Latin America Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 16: Europe Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 17: Europe Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 18: Europe Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 19: Europe Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 20: Europe Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 21: South Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 22: South Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 23: South Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 24: South Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 25: South Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 26: East Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 27: East Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 28: East Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 29: East Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 30: East Asia Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 31: Oceania Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 32: Oceania Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 33: Oceania Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 34: Oceania Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 35: Oceania Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 36: MEA Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 37: MEA Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 38: MEA Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 39: MEA Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 40: MEA Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 41: China Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 42: China Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 43: China Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 44: China Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 45: India Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 46: India Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 47: India Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 48: India Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel
Table 49: Brazil Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 50: Brazil Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Indication
Table 51: Brazil Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Route of Administration
Table 52: Brazil Biobetters Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Distribution Channel